fashion -WSS

fashion

author：fashion 2025-09-30 17:46:05 - browse：36378

Robert F. Kennedy Jr. said Tuesday that he will head up a panel on vaccine safety for Donald Trump.

The president-elect’s transition team spokeswoman later walked that back, saying that he is “exploring the possibility” of forming a panel on autism, but “no decisions have been made.”

Let’s hope Trump drops any idea of a vaccine panel headed by Kennedy. For more than a decade, Kennedy has promoted anti-vaccine propaganda completely unconnected to reality. If Kennedy’s panel leads to even a small decline in vaccine rates across the country, it will result in the waste of untold amounts of money and, in all likelihood, the preventable deaths of infants too young to be vaccinated.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Ebola public health emergency is over, WHO declares

WSS

'Reaching a detente': STAT's Helen Branswell on covering Covid

New warning issued for rebooking air travel after delays, cancellations

States increasingly look to regulate hospital facility fees

Why some people catch Covid but never get sick

FDA authorizes Novavax’s updated Covid

Why Charlie Gard's case is so disturbing to Americans

hotspot

fashion

entertainment

Drug repurposing or repositioning? The language matters

The kidney, in all its complexity, is captured in a new atlas

Novavax promises a turnaround & Lilly roils the obesity market

No Labels group has 'steep climb,' but third party 'worth trying': Larry Hogan

Anesthesiologist group: stop taking Ozempic before surgery

States increasingly look to regulate hospital facility fees

Affirmative action in medical school literally saved lives

New warning issued for rebooking air travel after delays, cancellations

In age of alternative facts, a scholarly course on calling out crap

Why the Crimean Bridge is key to Russia's war in Ukraine

explore

Physician executives need more than on

Analysis of telehealth claims data suggest service duplication

A Q&A with the global head of Boehringer Ingelheim's innovation unit

3 questions for the future of Biden's cancer moonshot

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

DOJ, FTC to increase scrutiny of all types of health care mergers

Wikipedia

knowledge

focus

entertainment